Package 63629-7269-1

{"route": ["SUBLINGUAL"], "spl_id": "2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9", "openfda": {"unii": ["5Q187997EE", "56W8MW3EN1"], "rxcui": ["351266", "351267"], "spl_set_id": ["2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (63629-7269-1)", "package_ndc": "63629-7269-1", "marketing_start_date": "20240402"}], "brand_name": "Buprenorphine HCl and Naloxone HCl", "product_id": "63629-7269_2aaad1a7-a0fd-4dd5-bb53-03afad8f10b9", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "63629-7269", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine HCl and Naloxone HCl", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "2 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": ".5 mg/1"}], "application_number": "ANDA203136", "marketing_category": "ANDA", "marketing_start_date": "20130222", "listing_expiration_date": "20261231"}